Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02060539 · ClinicalTrials.gov registry record · NA
Multicenter Dispensing Study of Biofinity Lenses in Extended Range
A NA study, sponsored by CooperVision.
- Completed
- Registry status
- NA
- Development phase
- 19
- Enrollment target
NCT02060539 is a NA study that has completed, run by CooperVision. The registered enrollment target is 19 participants.
The verdict
NCT02060539, a NA study, has completed, sponsored by CooperVision.
- COMPLETED
- Registry status
- NA
- Development phase
- 19 participants
- Enrollment target
Study Summary
To obtain subjective and objective feedback on the clinical performance of Biofinity lenses after at least two weeks daily wear in existing contact lens wearers compared with their habitual lenses.
Interventions
- DEVICE Biofinity XR
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 19 participants |
| Start Date | 2013-10 |
| Est. Completion | 2014-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02060539
The ClinicalTrials.gov registry entry for NCT02060539 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 19 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is CooperVision, which has 64 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Biofinity XR is the first listed.
NCT02060539 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02060539 about?
NCT02060539 is a clinical study titled "Multicenter Dispensing Study of Biofinity Lenses in Extended Range". To obtain subjective and objective feedback on the clinical performance of Biofinity lenses after at least two weeks daily wear in existing contact lens wearers compared with their habitual lenses.
What is the current status of trial NCT02060539?
This trial is currently completed. It is a NA study. The enrollment target is 19 participants. The study started on 2013-10. Estimated completion is 2014-12.
What interventions are being tested in trial NCT02060539?
The interventions under investigation include: Biofinity XR (DEVICE).
Who is sponsoring clinical trial NCT02060539?
This trial is sponsored by CooperVision, which has 64 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.